title: [Quincke's oedema or angioedema].
authors.affiliation: EA 3999: Maladies allergiques: diagnostic et thérapeutique, médecine interne, allergologie et immunologie clinique, CHU, Hôpital Central, 54035 Nancy cedex, France.
authors.forename: Maxime
authors.initials: M
authors.lastname: Hosotte
authors.forename: Sophie
authors.initials: S
authors.lastname: Jarlot
authors.forename: Samuel
authors.initials: S
authors.lastname: Luyasu
authors.forename: Gisèle
authors.initials: G
authors.lastname: Kanny
mesh_terms: D000799:Angioedema / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy*; D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001920:Bradykinin / Q000009:adverse effects / Q000502:physiology; D000075202:Contraindications; D003613:Danazol / Q000009:adverse effects / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D006632:Histamine / Q000009:adverse effects / Q000502:physiology; D006801:Humans; D015289:Leukotrienes / Q000009:adverse effects / Q000502:physiology; D008954:Models, Biological; D015398:Signal Transduction / Q000502:physiology; D014148:Tranexamic Acid / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000933:Antifibrinolytic Agents; D004965:Estrogen Antagonists; D015289:Leukotrienes; D014148:Tranexamic Acid; D006632:Histamine; D003613:Danazol; D001920:Bradykinin